Nanobodies: a promising approach to treatment of viral diseases

Registro completo de metadados
MetadadosDescriçãoIdioma
Autor(es): dc.contributorUniversidade Estadual Paulista (UNESP)-
Autor(es): dc.contributorAdolfo Lutz Institute-
Autor(es): dc.creatorMinatel, Vitória Meneghetti-
Autor(es): dc.creatorPrudencio, Carlos Roberto-
Autor(es): dc.creatorBarraviera, Benedito-
Autor(es): dc.creatorFerreira, Rui Seabra-
Data de aceite: dc.date.accessioned2025-08-21T18:55:50Z-
Data de disponibilização: dc.date.available2025-08-21T18:55:50Z-
Data de envio: dc.date.issued2025-04-29-
Data de envio: dc.date.issued2022-12-31-
Fonte completa do material: dc.identifierhttp://dx.doi.org/10.3389/fimmu.2023.1303353-
Fonte completa do material: dc.identifierhttps://hdl.handle.net/11449/300577-
Fonte: dc.identifier.urihttp://educapes.capes.gov.br/handle/11449/300577-
Descrição: dc.descriptionSince their discovery in the 1990s, heavy chain antibodies have garnered significant interest in the scientific community. These antibodies, found in camelids such as llamas and alpacas, exhibit distinct characteristics from conventional antibodies due to the absence of a light chain in their structure. Furthermore, they possess a single antigen-binding domain known as VHH or Nanobody (Nb). With a small size of approximately 15 kDa, these Nbs demonstrate improved characteristics compared to conventional antibodies, including greater physicochemical stability and enhanced biodistribution, enabling them to bind inaccessible epitopes more effectively. As a result, Nbs have found numerous applications in various medical and veterinary fields, particularly in diagnostics and therapeutics. Advances in biotechnology have made the production of recombinant antibodies feasible and compatible with large-scale manufacturing. Through the construction of immune phage libraries that display VHHs and subsequent selection through biopanning, it has become possible to isolate specific Nbs targeting pharmaceutical targets of interest, such as viruses. This review describes the processes involved in nanobody production, from hyperimmunization to purification, with the aim of their application in the pharmaceutical industry.-
Descrição: dc.descriptionCenter for the Study of Venoms and Venomous Animals (CEVAP) São Paulo State University (UNESP—Univ Estadual Paulista), São Paulo-
Descrição: dc.descriptionImmunology Center Adolfo Lutz Institute, São Paulo-
Descrição: dc.descriptionGraduate Program in Tropical Diseases Botucatu Medical School (FMB) São Paulo State University (UNESP—Univ Estadual Paulista), São Paulo-
Descrição: dc.descriptionCenter for the Study of Venoms and Venomous Animals (CEVAP) São Paulo State University (UNESP—Univ Estadual Paulista), São Paulo-
Descrição: dc.descriptionGraduate Program in Tropical Diseases Botucatu Medical School (FMB) São Paulo State University (UNESP—Univ Estadual Paulista), São Paulo-
Idioma: dc.languageen-
Relação: dc.relationFrontiers in Immunology-
???dc.source???: dc.sourceScopus-
Palavras-chave: dc.subjectcamelids-
Palavras-chave: dc.subjectheavy chain antibodies-
Palavras-chave: dc.subjectimmune library-
Palavras-chave: dc.subjectneutralizing antibodies-
Palavras-chave: dc.subjectphage display-
Palavras-chave: dc.subjectsingle domain antibodies-
Palavras-chave: dc.subjectVHH-
Título: dc.titleNanobodies: a promising approach to treatment of viral diseases-
Tipo de arquivo: dc.typevídeo-
Aparece nas coleções:Repositório Institucional - Unesp

Não existem arquivos associados a este item.